Understanding Advanced Prostate Cancer

Types of Advanced Prostate Cancer

Understanding how your cancer responds to hormone levels helps your care team select the most effective treatment:

• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): The cancer has spread outside the prostate, but it still responds to treatments that lower testosterone levels.
• Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC): Blood tests show rising PSA levels despite low testosterone, but imaging scans show no visible spread to other parts of the body.
• Metastatic Castration-Resistant Prostate Cancer (mCRPC): The cancer continues to grow or spread even when testosterone levels in the body are suppressed to extremely low levels.

Treatment Options for Advanced Prostate Cancer

Treatment plans for advanced prostate cancer are tailored specifically to your stage of disease, overall health, and personal goals. Most patients receive a combination of therapies over time.

1. Hormone Therapy (Androgen Deprivation Therapy – ADT)

Prostate cancer cells rely on male hormones (androgens), primarily testosterone, to grow. ADT works by lowering testosterone levels or blocking it from reaching cancer cells.

• Injectable Therapies (LHRH Agonists/Antagonists): Medications given as periodic injections (every 1 to 6 months) that signal the body to stop producing testosterone in the testicles.
• Oral Anti-Androgens: Daily pills that prevent testosterone from attaching to prostate cancer cells.

2. Next-Generation Hormonal Agents (ARPIs)

For disease that is aggressive or no longer responding to traditional ADT alone, advanced oral medications provide powerful additional hormone blockade:

• Androgen Receptor Pathway Inhibitors (ARPIs): Medications such as abiraterone, enzalutamide, apalutamide, and darolutamide block androgen production or prevent hormone receptors from signaling cancer cell growth.

3. Targeted Radiopharmaceuticals (PSMA-Targeted Therapy)

Prostate-Specific Membrane Antigen (PSMA) is a protein found in high amounts on the surface of most prostate cancer cells.

• PSMA Theranostics (e.g., Pluvicto®): An innovative targeted therapy that combines a diagnostic PSMA PET scan with a therapeutic radioactive molecule. The drug attaches directly to PSMA proteins on cancer cells throughout the body and delivers targeted radiation to destroy them while sparing healthy surrounding tissue.

4. Chemotherapy

Chemotherapy uses cancer-killing medications administered intravenously to destroy fast-growing cancer cells throughout the body.

• When it is used: Commonly recommended for metastatic disease that is spread widely, growing quickly, or no longer responding to hormone therapies alone (e.g., docetaxel or cabazitaxel).

5. Immunotherapy & Precision Medicine

Precision oncology uses genetic testing of your tumor or blood to identify specific gene mutations that can be targeted with specialized drugs.

• PARP Inhibitors: Oral targeted therapies (such as olaparib or rucaparib) for men whose tumors have specific DNA repair gene mutations (like BRCA1 or BRCA2).
• Cancer Vaccines (e.g., Provenge® / Sipuleucel-T): A personalized cellular immunotherapy that trains your body’s own immune system to recognize and attack prostate cancer cells.

6. Bone-Targeted Therapies & Symptom Management

Prostate cancer most commonly spreads to the bones. Protecting bone health and managing symptoms is a vital part of comprehensive care:

• Bone-Protecting Agents: Medications (such as denosumab or zoledronic acid) help strengthen bones, reduce bone pain, and prevent fractures.
• Targeted Bone Radiopharmaceuticals: Treatments that target active bone metastases to relieve pain and improve survival.

What to Expect During Your Care

1. Comprehensive Staging: We utilize advanced imaging—including high-resolution PSMA PET/CT scans—to precisely locate where cancer cells are present in the body.
2. Genetic & Biomarker Testing: We test both inherited DNA and tumor tissue to determine if precision therapies or clinical trials are right for you.
3. Multidisciplinary Teamwork: Your care is coordinated among urologists, medical oncologists, radiation oncologists, and supportive care specialists to ensure a seamless treatment experience.